|
...million, up 2% year-over-year
Operating income of $8.1 million; operating margin of 48%
Net income of $6.0 million
Diluted EPS of $0.32
Operating cash flow of $11.8 million Non-CYPHER-related revenue increased 23% year-over-year Two new licenses signed with SurModics customers
Four new customer products introduced
Completed the repurchase of $17.5 million of common stock "SurModics is pleased to report 23% growth in non-CYPHER revenue for the first quarter of fiscal year 2007," said Bruce Barclay, president and CEO. "Our overall performance during the period was...
NOTE: All illustrations and photos
have been removed from this article.
More articles from Biotech Financial Reports
PAREXEL REPORTS 2ND QTR FISCAL 2007 NET INCOME OF $9.1 MIL.(Company ov..., March 01, 2007
BAXTER'S ACHIEVED RECORD SALES/EARNINGS IN 2006.(Financial report), March 01, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
%20%20&position=1)